News Search Results
Oct 22, 2025, 16:01 ET Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025
known subtypes of hepatitis B virus in adults 18 years of age and older, and CpG 1018® adjuvant, currently used in HEPLISAV-B and multiple adjuvanted COVID-19 vaccines. For more information about our marketed products and development pipeline, visit
More news about: Dynavax Technologies
Oct 22, 2025, 11:00 ET Psilocybin + Mindfulness Shows Promise for Healthcare Worker Depression: Report
CITY, Oct. 22, 2025 /PRNewswire/ -- Frontline healthcare workers struggling with depression after the COVID-19 pandemic experienced significant relief from a treatment combining psilocybin group therapy with mindfulness training, according to a new study from
More news about: Huntsman Mental Health Institute
Oct 22, 2025, 10:31 ET New Research Shows Mid-Sized Charities Outperform Peers in Financial Health
liquidity and debt concerns for mid-sized nonprofits. Learn from nonprofits that successfully navigated the challenges of the COVID-19 pandemic, adopting strategies such as maintaining higher operating reserves, enhancing financial flexibility, and diversifying revenue streams to
More news about: Bernstein Private Wealth Management
Oct 22, 2025, 09:00 ET Manisha Juthani, MD, Commissioner of Connecticut Department of Public Health, Announced as Next ASTHO President
As Connecticut's health commissioner who assumed the role in the midst of the COVID-19 pandemic, Dr. Juthani led the state's efforts to transition the public health response as Connecticut emerged from the pandemic. Her efforts then
More news about: Association of State and Territorial Health Officials
Oct 22, 2025, 08:44 ET Credibly Secures Patent for Proprietary AI SMB Lending Platform
servicing rights to another alternative lender's portfolio ($250 million). The company has achieved steady growth, operated continuously throughout the COVID-19 pandemic, and recorded exceptional origination numbers. Credibly's headquarters are in Southfield, Michigan, with offices in
More news about: Credibly
Oct 22, 2025, 07:00 ET Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy
Novavax to pursue planned regulatory pathways; challenges or delays in obtaining regulatory authorization for a JN.1 protein-based COVID-19 vaccine or for future COVID-19 variant strain changes; challenges or delays in clinical trials; manufacturing, distribution or export delays or challenges; Novavax's
More news about: Novavax, Inc.
Oct 22, 2025, 06:04 ET American Lung Association Launches Campaign to Educate People Living With Lung Cancer and Lung Disease About Critical Vaccines
65% of COVID-19 vaccine-eligible adults 65 or older who were hospitalized had no record of receiving the recommended COVID-19 vaccine last season. The Lung Association encourages individuals to
More news about: American Lung Association
Oct 22, 2025, 05:57 ET Taiwan Showcases Evidence-Based TCM at CPHI Frankfurt 2025
series of national TCM innovations developed by the National Research Institute of Chinese Medicine (NRICM): NRICM101 and NRICM102 for COVID-19, NRICM201 for dementia, and NRICM301 for post-stroke recovery. Among these, only NRICM101 and NRICM102 have reached the market, widely
More news about: Taiwan Institute of Economic Research
Oct 22, 2025, 03:27 ET Taiwan présente la TCM fondée sur des données probantes à CPHI de Francfort 2025
d'innovations nationales en matière de TCM mises au point par National Research Institute of Chinese Medicine (NRICM) : NRICM101 et NRICM102 pour COVID-19, NRICM201 pour la démence, et NRICM301 pour la récupération post-AVC. Parmi ces médicaments, seuls NRICM101 et NRICM102, largement
More news about: Taiwan Institute of Economic Research
Oct 21, 2025, 19:30 ET PADCEV™ (enfortumab vedotin-ejfv) Plus KEYTRUDA® (pembrolizumab) sBLA Granted FDA Priority Review for Treatment of Certain Patients with Muscle-Invasive Bladder Cancer
PADCEV occurred in 73% of patients. The most common adverse reactions (≥2%) leading to dose interruption of PADCEV were PN (22%), rash (16%), COVID19 (10%), diarrhea (5%), pneumonitis/ILD (4.8%), fatigue (3.9%), hyperglycemia (3.6%), increased ALT (3%) and pruritus (2.5%). Adverse reactions leading
More news about: Astellas Pharma Inc.
Oct 21, 2025, 16:01 ET Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial
of hepatitis B virus in adults 18 years of age and older, and CpG 1018® adjuvant, currently used in HEPLISAV-B and multiple adjuvanted COVID-19 vaccines. For more information about Dynavax's marketed products and development pipeline, visit
More news about: Dynavax Technologies
Oct 21, 2025, 14:33 ET Researchers Link Orphan Gene in SARS-CoV-2 Virus to More Severe Cases of COVID-19
orphan gene, ORF10, in SARS-CoV-2, the virus responsible for COVID-19. However, the role ORF10 played in COVID-19 outcomes in humans remained unknown. As part of the work being done by the COVID-19 International Research Team (COV-IRT), this study combined lab experiments,
More news about: Children's Hospital of Philadelphia
Oct 21, 2025, 11:50 ET Pioneering Physician-Scientist Dr. Francis S. Collins Joins ImmunoBrain Board of Directors
trials, as well as a historic series of research partnerships that included addressing Alzheimer's disease, cancer, precision health, neuroscience, and COVID-19. In addition, Dr. Collins led an active research group at the University of Michigan and the NIH for 41 years, doing groundbreaking research on type
More news about: ImmunoBrain Checkpoint Inc.
Oct 21, 2025, 10:54 ET Caterpillar Invests in U.S. Manufacturing and Future Workforce Skills Training
laws and regulations; (xxvi) the duration and geographic spread of, business disruptions caused by, and the overall global economic impact of, the COVID-19 pandemic; and (xxvii) other factors described in more detail in Caterpillar's Forms 10-Q, 10-K and other filings with the Securities and Exchange
More news about: Caterpillar Inc.
Oct 21, 2025, 08:05 ET Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine
people from HPV-related diseases, cancer, and infectious diseases, today announced results from a Phase 1 proof-of-concept trial evaluating DMAbs for COVID-19 were published online in Nature Medicine under the title "
More news about: INOVIO Pharmaceuticals, Inc.
Oct 21, 2025, 05:22 ET Taiwán presenta TCM basada en la evidencia en CPHI Frankfurt 2025
innovaciones nacionales en TCM desarrolladas por el Instituto Nacional de Investigación de Medicina China (NRICM): NRICM101 y NRICM102 para la COVID-19, NRICM201 para la demencia y NRICM301 para la recuperación tras un accidente cerebrovascular. Entre estas, solo NRICM101 y NRICM102 han llegado
More news about: Taiwan Institute of Economic Research
Oct 21, 2025, 05:20 ET Taiwan präsentiert evidenzbasierte TCM auf der CPHI Frankfurt 2025
nationalen TCM-Innovationen, die vom National Research Institute of Chinese Medicine (NRICM) entwickelt wurden: NRICM101 und NRICM102 für COVID-19, NRICM201 für Demenz und NRICM301 für die Erholung nach einem Schlaganfall. Von diesen haben nur NRICM101 und NRICM102 den Markt erreicht,
More news about: Taiwan Institute of Economic Research
Oct 21, 2025, 05:05 ET Mercantile Bank Corporation Announces Strong Third Quarter 2025 Results
expectations and other facts; changes in the national and local economies; unstable political and economic environments; disease outbreaks, such as the COVID-19 pandemic or similar public health threats, and measures implemented to combat them; and other factors, including those expressed as risk factors,
More news about: Mercantile Bank Corporation
Oct 21, 2025, 05:00 ET Mercantile Bank Corporation Declares Regular Cash Dividend
expectations and other facts; changes in the national and local economies; unstable political and economic environments; disease outbreaks, such as the COVID-19 pandemic or similar public health threats, and measures implemented to combat them; and other factors, including those expressed as risk factors,
More news about: Mercantile Bank Corporation
Oct 20, 2025, 16:10 ET W. R. Berkley Corporation Reports Third Quarter 2025 Results
which we rely could expose us to technological, security, legal, and other risks; the risk of future pandemics, as well as continuing effects of the COVID-19 pandemic; foreign currency and political risks relating to our international operations; our ability to attract and retain key personnel and qualified
More news about: W.R. BERKLEY CORPORATION
Oct 20, 2025, 09:05 ET CUMBERLAND PHAMACEUTICALS ANNOUNCES THE ADDITION OF AN ESTABLISHED FDA APPROVED PRODUCT TO ITS COMMERCIAL PORTFOLIO
for development for radiation and chemical exposure indications such as GI-Acute Radiation Syndrome (GI-ARS), a Phase 2/3 program for hospitalized COVID-19, and a Phase 2 study in prostate cancer in combination with darolutamide; (ii) RHB-204, a next-generation optimized formulation of RHB-104,
More news about: Cumberland Pharmaceuticals Inc.
Oct 20, 2025, 09:00 ET RedHill's Talicia® Secures $4 Million Strategic Investment and U.S. Co-Commercialization Partnership Deal
for development for radiation and chemical exposure indications such as GI-Acute Radiation Syndrome (GI-ARS), a Phase 2/3 program for hospitalized COVID-19, and a Phase 2 study in prostate cancer in combination with darolutamide; (ii) RHB-204, a next-generation optimized formulation of RHB-104,
More news about: RedHill Biopharma Ltd.
Oct 20, 2025, 07:00 ET Westbridge Renewable Energy to Present at the Planet MicroCap Showcase in Toronto
terms acceptable to the Company or at all. Applicable risks and uncertainties include, but are not limited to regulatory risks, risks related to the COVID-19 global pandemic, changes in laws, market risks, operating history, competition, and the other risks identified under the headings "Risk Factors" in
More news about: Westbridge Renewable Energy Corp.
Oct 19, 2025, 22:33 ET ACROBiosystemsはパートナーと共催で、OrganoAsia 2025を大盛況のうちに開催
Toolbox を通じて、研究者が有効性スクリーニング、毒性評価、薬理研究をより効率的に行えるよう、包括的なソリューションを提供しています。 中国南方科技大学（SUSTech）医学部 Li Liang 教授のグループは、臓器の微小環境を正確に再現する患者由来オルガノイドのバイオバンクを構築しました。COVID-19 パンデミック中、同グループは呼吸器オルガノイドプラットフォームを用いて、SARS-CoV-2 の各変異株間の組織親和性の違いを特定しました。たとえば、デルタ株は肺炎を引き起こした一方で、オミクロン BA.2 は主に上気道に感染しました。ハイス
More news about: ACROBiosystems Group
Oct 19, 2025, 10:49 ET iOncologi Secures Foundational U.S. Patent as Landmark Studies Link COVID19 mRNA Vaccines to Improved Survival with Cancer Immunotherapy
multimedia:https://www.prnewswire.com/news-releases/ioncologi-secures-foundational-us-patent-as-landmark-studies-link-covid19-mrna-vaccines-to-improved-survival-with-cancer-immunotherapy-302588396.html
More news about: iOncologi, Inc.